Gamaleya Research Institute of Epidemiology and Microbiology

The Brazilian Ministry of Health signed on Friday a contract to receive 10 million doses of the Sputnik V vaccine, developed by Russia's Gamaleya Institute.
According to a federal law sanctioned at the beginning of the pandemic last year, Anvisa has 72 hours to decide whether or not to validate the registration of a Covid-19 vaccine granted by one of the national health agencies of the United States, the European Union, Japan and China - Sputnik was approved in Russia and also in Argentina.